RESUMEN

Obesity represents a major public health problem with a prevalence increasing at an alarming rate worldwide. Continuous intensive efforts to elucidate the complex pathophysiology and improve clinical management have led to a better understanding of biomolecules like gut hormones, antagonists of orexigenic signals, stimulants of fat utilization, and/or inhibitors of fat absorption. In this article, we will review the pathophysiology and pharmacotherapy of obesity including intersection points to the new generation of antidiabetic drugs. We provide insight into the effectiveness of currently approved anti-obesity drugs and other therapeutic avenues that can be explored.

Asunto(s)

Fármacos Antiobesidad/uso terapéutico , Diabetes Mellitus/tratamiento farmacológico , Metabolismo Energético/genética , Obesidad/tratamiento farmacológico , Diabetes Mellitus/etiología , Diabetes Mellitus/fisiopatología , Humanos , Obesidad/complicaciones , Obesidad/metabolismo , Obesidad/fisiopatología , Factores de Riesgo